GENE ONLINE|News &
Opinion
Blog

Special
Special 2022 psychedelics
Low Doses of LSD as a Potential Treatment for Anxiety in the Future?
2022-03-22
Feature 2022 psychedelics
History on Depression Therapy: the Past and the Psychedelic Future
2022-03-21
Special 2022 psychedelics
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
Special 2022 psychedelics
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
Deals BIO CEO & Investor Digital Conference
BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
2022-02-26
Special
The Golden Age of Genomics Sequencing
2022-02-20Partner
In-Depth BioJapan
Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
2022-02-14
Special Best of 2021
GeneOnline’s Pick: Novel Biotechnologies that Made a Splash in 2021
2022-01-27
Special China
Biotech Showcase 2022: The China Factor
2022-01-24
Go Prime NASDAQ
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Special Mental Disorder
Biotech Showcase 2022: Healing the Psyche with Psychedelia
2022-01-17
Special Breast Cancer
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Feature JPM
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
Special JPM
JPM22 Highlights: Cell and Gene Therapies Rise Up
2022-01-11
Go Prime Regenerative Medicine
As Regenerative Medicine Grows in Japan, Challenges Remain
2021-12-24
1 … 11 12 13 14 15 … 20
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top